PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China; Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.\', \'Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China; Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China; State Key Laboratory of Medical Genomics & Shanghai Institute of Hypertension, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China.\', \'Department of endocrinology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.\', \'Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.\', \'State Key Laboratory of Medical Genomics & Shanghai Institute of Hypertension, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China.\', \'Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.\', \'Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China; Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China; State Key Laboratory of Medical Genomics & Shanghai Institute of Hypertension, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China. Electronic address: jczhong@sina.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0167-5273(21)00841-X10.1016/j.ijcard.2021.05.029
?:hasPublicationType
?:journal
  • International journal of cardiology
is ?:pmid of
?:pmid
?:pmid
  • 34000358
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.2
?:rankingScore_hIndex
  • 103
is ?:relation_isRelatedTo_publication of
?:title
  • Abnormal apelin-ACE2 and SGLT2 signaling contribute to adverse cardiorenal injury in patients with COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all